345 related articles for article (PubMed ID: 29946255)
21. Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review.
Adam SS; McDuffie JR; Ortel TL; Williams JW
Ann Intern Med; 2012 Dec; 157(11):796-807. PubMed ID: 22928173
[TBL] [Abstract][Full Text] [Related]
22. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.
Akl EA; Labedi N; Barba M; Terrenato I; Sperati F; Muti P; Schünemann H
Cochrane Database Syst Rev; 2011 Jun; (6):CD006650. PubMed ID: 21678361
[TBL] [Abstract][Full Text] [Related]
23. Real-world data emulating randomized controlled trials of non-vitamin K antagonist oral anticoagulants in patients with venous thromboembolism.
Yoon D; Jeong HE; Park S; You SC; Bang SM; Shin JY
BMC Med; 2023 Sep; 21(1):375. PubMed ID: 37775786
[TBL] [Abstract][Full Text] [Related]
24. Risk of major bleeding in different indications for new oral anticoagulants: insights from a meta-analysis of approved dosages from 50 randomized trials.
Sardar P; Chatterjee S; Lavie CJ; Giri JS; Ghosh J; Mukherjee D; Lip GY
Int J Cardiol; 2015 Jan; 179():279-87. PubMed ID: 25464465
[TBL] [Abstract][Full Text] [Related]
25. Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer.
Akl EA; Barba M; Rohilla S; Terrenato I; Sperati F; Muti P; Schünemann HJ
Cochrane Database Syst Rev; 2008 Apr; (2):CD006650. PubMed ID: 18425959
[TBL] [Abstract][Full Text] [Related]
26. Non-vitamin K oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolic disease.
Voukalis C; Lip GY; Shantsila E
Expert Opin Pharmacother; 2016 Oct; 17(15):2033-47. PubMed ID: 27667112
[TBL] [Abstract][Full Text] [Related]
27. Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER
Feuring M; Schulman S; Eriksson H; Kakkar AJ; Schellong S; Hantel S; Schueler E; Kreuzer J; Goldhaber SZ
J Thromb Thrombolysis; 2017 May; 43(4):484-489. PubMed ID: 28210989
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy and safety of non-vitamin K antagonist versus vitamin K antagonist oral anticoagulants in the prevention and treatment of thrombotic disease in active cancer patients: a systematic review and meta-analysis of randomized controlled trials].
Wang CX; Wu D; Yang PP; Wu QH
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug; 48(8):689-696. PubMed ID: 32847326
[No Abstract] [Full Text] [Related]
29. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
Hillis C; Crowther MA
Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.
Rollins BM; Silva MA; Donovan JL; Kanaan AO
Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394
[TBL] [Abstract][Full Text] [Related]
31. Anticoagulation in Venous Thromboembolism Prophylaxis in Medically Ill Patients: Potential Impact of NOACs.
Knotts TL; Mousa SA
Am J Cardiovasc Drugs; 2019 Aug; 19(4):365-376. PubMed ID: 30809772
[TBL] [Abstract][Full Text] [Related]
32. Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolism.
Kang N; Sobieraj DM
Thromb Res; 2014 Jun; 133(6):1145-51. PubMed ID: 24713109
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Direct Oral Anticoagulants in Venous Thromboembolism Compared to Traditional Anticoagulants in Morbidly Obese Patients: A Systematic Review and Meta-Analysis.
Katel A; Aryal M; Neupane A; Gosain R; Pathak R; Bhandari Y; Kouides P
Cureus; 2021 Apr; 13(4):e14572. PubMed ID: 34026385
[TBL] [Abstract][Full Text] [Related]
34. New Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Total Hip and Knee Arthroplasty: A Systematic Review and Network Meta-Analysis.
Yi YH; Gong S; Gong TL; Zhou LY; Hu C; Xu WH
Front Pharmacol; 2021; 12():775126. PubMed ID: 35111051
[No Abstract] [Full Text] [Related]
35. The role of anticoagulation in venous thromboembolism primary prophylaxis in patients with malignancy: A systematic review and meta-analysis of randomized controlled trials.
Barbarawi M; Zayed Y; Kheiri B; Gakhal I; Barbarawi O; Bala A; Alabdouh A; Abdalla A; Rizk F; Bachuwa G; Katato K
Thromb Res; 2019 Sep; 181():36-45. PubMed ID: 31349093
[TBL] [Abstract][Full Text] [Related]
36. Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.
Gómez-Outes A; Terleira-Fernández AI; Lecumberri R; Suárez-Gea ML; Vargas-Castrillón E
Thromb Res; 2014 Oct; 134(4):774-82. PubMed ID: 25037495
[TBL] [Abstract][Full Text] [Related]
37. Sex related differences in patients with acute venous thromboembolism treated with new oral anticoagulants. A meta-analysis of the interventional trials.
Loffredo L; Violi F; Perri L
Int J Cardiol; 2016 Jun; 212():255-8. PubMed ID: 27057930
[TBL] [Abstract][Full Text] [Related]
38. A Renal Function Based Trade-Off Analysis of Non-vitamin K Antagonist Oral Anticoagulants in Nonvalvular Atrial Fibrillation.
Zhou LY; Yang SF; Zhang Z; Zhang C; Shen L; Gu ZC; Zuo XC
Front Physiol; 2018; 9():1644. PubMed ID: 30524307
[No Abstract] [Full Text] [Related]
39. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
Beyer-Westendorf J; Ageno W
Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
[TBL] [Abstract][Full Text] [Related]
40. New oral anticoagulants for the treatment of acute venous thromboembolism: are they safer than vitamin K antagonists? A meta-analysis of the interventional trials.
Loffredo L; Perri L; Del Ben M; Angelico F; Violi F
Intern Emerg Med; 2015 Jun; 10(4):499-506. PubMed ID: 25539954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
